Addressing diminished treatment options in the omicron wave, the Biden administration has purchased enough of a yet-to-be approved antibody drug to treat 600,000 COVID-19 patients, officials said Thursday.
The new monoclonal antibody from pharmaceutical giant Eli Lilly will be shipped out to states free of charge if the Food and Drug Administration approves the company's request for emergency use authorization, said Health and Human Services Secretary Xavier Becerra “We are going to try to be there to meet the demand,” he added.
